SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Xencor (XNCR)
An SI Board Since January 2014
Posts SubjectMarks Bans Symbol
136 22 0 XNCR
Emcee:  scaram(o)uche Type:  Moderated
Introduction Market Data Compact
I've been putting some Xencor stuff here. No reason for doing so, just blogging in that thread with irrelevant stuff......

Subject 59375

And it's probably also worth the time, following the MGNX thread.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
136Thanks, Lance. Dahiyat has vision. Pipeline continues to expand, complex businscaram(o)uche-12/5/2021
135Apparently little interest in XNCR by others but I've been playing around wiLance Bredvold-10/22/2021
134(was supposed to be a PM)scaram(o)uche-2/25/2019
133More success here with AE. amphivena.comgcrispin-2/21/2019
132CD123 was (and is) hot target, therapeutic window is small (so far)... Dual tarMiljenko Zuanic-2/20/2019
131Thanks :(atticus4paws-2/20/2019
130Go to the very end of the AML update in December, and you'll hear "nextscaram(o)uche-2/20/2019
129It's wholly owned, to my knowledge. We get a 10-K within a couple of weeks,scaram(o)uche-2/20/2019
128In October 2018, XNCR again said that they planned to start a P3 for XmAb5871 inatticus4paws-2/20/2019
127a good follow.... twitter.comscaram(o)uche-2/20/2019
126I never would have predicted this, but the literature re. IgG4-related disease hscaram(o)uche-2/20/2019
125XNCR is definitely most close bio, from my location. So, I can do *visual inspecMiljenko Zuanic-2/20/2019
124CD123 x CD3 bispecific placed on partial clinical hold. Two patients, one CRS ascaram(o)uche-2/20/2019
123I am surprise (and bit distract) that Merck did not swap XmAb24306? They can spaMiljenko Zuanic-2/5/2019
122(the link in post 117 doesn't lead to today's PR, it leads to an AACR poscaram(o)uche-2/5/2019
121>> PS: XmAb24306 is not bispecific Abs << Yes, thank you. I'vescaram(o)uche-2/5/2019
120GNE has its own IL2 candidate, so IL15 may be complementary and make sense to doMiljenko Zuanic-2/5/2019
119BTW, it's largely gone unnoticed that the "Xtend" Fc has received scaram(o)uche-2/5/2019
118I once predicted that the Fc's would end up being the products. Hasn't scaram(o)uche-2/5/2019
117Really blah reaction to today's news, up only a buck and change when the upfscaram(o)uche-2/5/2019
116Thanks, makes sense!scaram(o)uche-1/7/2019
115Just opened the slides aobut 20 min ago. TSAs are undisclosed tumor specific Biotech Jim-1/7/2019
114Slide 24 (certain that you've seen it by now)...... plenty of CRs, and yescaram(o)uche-1/7/2019
113<Morning, Jim! Good 2019 to you!> Best of health and happiness to you (anBiotech Jim-1/7/2019
112Don't know, but looks like REGN also got theirs back from Sanofi? 14045.....scaram(o)uche-1/7/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News